Search

Sort by:
Results 12681 - 12690 of 24815 for AIDS
  • Novel target for therapeutics against Staphylococcus aureus
    News - 28 Nov 2008
    Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology, and the University of Edinburgh have uncovered how a bacterial pathogen interacts with the blood coagulation...
  • Anti-herpes drug acyclovir inhibits HIV replication, but with a price
    News - 7 Nov 2008
    The anti-herpes drug acyclovir can also directly slow down HIV infection by targeting the reverse transcriptase (RT) enzyme, researchers report in this week's JBC.
  • Advancing medical research
    News - 26 Oct 2008
    Researchers from the University of Essex and medical counterparts from Colchester Hospital University NHS Foundation Trust are working together to develop successful partnerships in advancing medical...
  • New study on rural HIV shows significant stigma and discrimination in the rural medical referral system
    News - 11 Sep 2008
    An Indiana University study found that HIV care providers in rural Indiana report significant stigma and discrimination in the rural medical referral system surrounding issues of HIV and substance...
  • Genetic testing for sudden cardiac death
    News - 31 Aug 2008
    Sudden Cardiac Death (SCD) is a major contributor to mortality in industrialized nations, affecting around 500,000 individuals annually in the Western World, and causing more deaths than AIDS, lung...
  • A new target for malaria drugs
    News - 4 Aug 2008
    The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria...
  • MedMira Inc. awarded US patent for rapid test technology
    News - 17 Jul 2008
    MedMira Inc. announced today that it received a Notice of Allowance from the United States Patent and Trademark Office for its rapid flow-through test (RFT) methodology, the technology platform its...
  • Samaritan Pharmaceuticals granted IND from FDA for HIV drug
    News - 8 Jul 2008
    Samaritan Pharmaceuticals has announced that it has filed an IND (Investigational New Drug) application for SP-6310 in the treatment of HIV-infected patients with abnormal cortisol levels.
  • Rapid prototyping technology builds bones
    News - 8 Jul 2008
    Individual bone implants whose structure resembles that of the natural bone can now be produced quite easily. First, a simulation program calculates the bone's internal structure and porosity, then a...
  • Asthma risk increases in children treated for HIV
    News - 1 Jul 2008
    Children whose immune systems rebound after treatment with potent anti-viral drugs for HIV infection face an increased risk of developing asthma, said a federally funded consortium of researchers led...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback